Non-regulatory Press releases
PILA PHARMA ANNOUNCES INITIATION OF STUDY IN PRECLINICAL RESEARCH COLLABORATION IN CARDIOVASCULAR DISEASE
Malmö, 21 November 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") today announces the initiation of the study associated to the co-sponsorship of the research collaboration with the Research Group of Professor Dick Wågsäter, Uppsala University, Sweden (the "Research Group"). The aim is to complete initial investigations on the effect of PILA PHARMA's lead molecule, XEN-D0501, on Abdominal Aorta…
PILA PHARMA INVITES TO NORDIC INVESTOR MEETINGS
Malmö, 20 November 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") (FN STO: PILA) hereby invites you to participate in these upcoming Nordic investor events: ___________AktieInfo Investor Evening (Aalborg, Denmark)Monday, 25 November 2024 from 17:00 CETAktieInfo Investor Evening (Kolding, Denmark)Tuesday, 26 November 2024 from 17:00 CET Aktiespararna 'Stora Aktiedagarna' (ONLINE / Stockholm, Sweden)Thursday, 28 November 2024 from 14:30 CET Redeye Technology…
PILA PHARMA AB Chairman & CEO increase their holdings
Malmö, 19 November 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company"), (FN STO: PILA), today announces that Chairman of the Board, Dorte X. Gram and CEO Gustav H. Gram have purchased additional shares. The purchases were conducted in two separate entities.Firstly, PILA PHARMA Chairman of the Board, Dorte X. Gram, together with CEO Gustav H. Gram, have acquired additional…
PILA PHARMA TO PARTICIPATE IN DANISH INVESTMENT PODCAST “MILLIONÆRKLUBBEN”
Malmö, 14 November 2024 PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to view and/or listen to the broadcast from todays episode of "Millionærklubben" (Millionaire's Club) where PILA PHARMA's CEO Gustav H. Gram will participate. CEO Gustav H. Gram is invited to elaborate on PILA PHARMA and answer questions from the experts and listeners about the rationale of the…
CEO Gustav H. Gram increases holding in PILA PHARMA AB
Malmö, 02 September 2024 Pila Pharma AB (publ) (FN STO: PILA) announces that recently appointed CEO Gustav H. Gram has purchased additional shares. The purchases occurred on Wednesday, 30 August, where 29.375 shares in the company were acquired. The shares were purchased at an average price of SEK 5,1768.___Mr. Gram's direct holdings in Pila Pharma AB now amounts to 74.816 shares.CEO Gustav H…